ISAP Researchers' Profiles

Jerry Cartier, M.A.

Jerry Cartier, M.A. Staff Research Associate IV. Mr. Cartier has considerable experience in the drug and alcohol treatment field as a practitioner, administrator, and researcher. Mr. Cartier served as Executive Director of the Thresholds to Recovery treatment program in Santa Barbara, California (1994-1998). After joining UCLA-ISAP in 1998, he became Study Director for a five-year (1997-2003) evaluation of the California Substance Abuse Treatment Facility/State Prison (SATF) treatment programs. He served as Study Director for a three-year extended evaluation of the SATF, as well as Study Director for a recently awarded 4-year continuation of the SATF evaluation. He is Study Director for the Transitional Case Management Study (TCM). TCM is one of several NIDA-funded studies in the Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) nationwide initiative. He is also Study Director for a NIDA-funded pilot study entitled, "Gender Responsive Treatment for Women in Prison" and Project Coordinator for a NIDA-funded study entitled “Behavioral Reinforcement to Increased Treatment Engagement (BRITE). BRITE is being conducted in partnership with the Washington State Department of Corrections and is testing the efficacy of contingency management in an in-prison therapeutic community for substance abuse treatment.

Education and Training

• Bachelor of Arts, Antioch University 1996, Psychology
• Master of Arts, Antioch University 1997, Organizational Management
• Certification: Alcohol and Other Drug Counseling Skills, University of California, Santa Barbara, 1994
• Certification: Alcohol and Drug Counselor, Fighting Back Program of Santa Barbara, Council on Alcoholism and Drug Abuse, 1995

Specialties

Mr. Cartier’s areas of specialization include the evaluation of in-prison substance abuse treatment programs including implementation and process issues as well as client outcomes. Mr. Cartier has also spent considerable research time in investigating the transition process and outcomes of post-release (aftercare) services for offenders retuning to the community. With the recent rapid increase in the use of Methamphetamine (MA) among the offending population, Mr. Cartier has begun to focus on the association between MA use and HIV/AIDS risk behaviors among offenders.

Contact Info

Jerry Cartier, MA
UCLA Integrated Substance Abuse Programs
David Geffen School of Medicine
Semel Institute for Neuroscience and Human Behavior
1640 S. Sepulveda Blvd., Suite 200
Los Angeles, CA 90025
Office: 310-267-5542
Fax: 310-312-0559
jcartier@ucla.edu

Selected Publications

Cartier, J., Greenwell, L. & Prendergast, M. L. (in submission). The persistence of HIV risk behavior among Methamphetamine-using offenders.

Prendergast, M. & Cartier, J. (2008). Improving parolee’s participation in drug treatment and other services through strengths case management. Perspectives. 32 (1) 38-46

Grella, C., Greenwell, L., Prendergast, M., Farabee, D., Hall, E., Cartier, J., & Burdon, W. (2007). Organizational characteristics of drug abuse treatment programs for offenders. Journal of Substance Abuse Treatment. 32 291-300

Cartier, J., Farabee, D., and Prendergast, M. L. (2006). Methamphetamine use, self-reported violent crime and recidivism among offenders in California who abuse substances. Journal of Interpersonal Violence, 21 (4) 435-445

Farabee, D., Shen, H., Prendergast, M.L., & Cartier, J. (2004). The effectiveness of coerced admission to prison-based drug treatment. In K. Knight & D. Farabee (Eds.) Treating addicted offenders: A continuum of effective practices (Chap.31, pp.1-12). Kingston, NJ: Civic Research Institute.

Burdon, W.M., Farabee, D., Prendergast, M. L., Messina, N. P., Cartier, J. (2002). Prison-based substance Abuse programs: Implementation and operational issues. Federal Probation, 66 (3), 3-8

Prendergast, M.L., Farabee, D. & Cartier, J. (2002) ­ Corrections-based substance abuse programs: good for inmates, good for prisons. Offender Substance Abuse Report, 2 (6)  81-92

Farabee, D., Prendergast, M. L. & Cartier, J. (2002). Alcohol the “undrug”, Psychiatric Services, 53 (11)  1375-1376

Farabee, D., Prendergast, M. L. & Cartier, J. (2002). Methamphetamine use and HIV risk among substance-abusing offenders in California. Journal of Psychoactive Drugs, 34 (3) 295-300

Prendergast, M. L., Farabee, D., Cartier, J. & Henkin,  (2002).  Involuntary
Treatment within a prison setting: impact on psychological change during
treatment. Criminal Justice and Behavior, 29 (1), 5-26
Deitch, D., Koutsenouk, I., Burgener, M. & Cartier, J. (2001).  Does in-custody therapeutic community substance abuse treatment impact custody personnel?
Corrections Compendium, 26 (2), 153-161

Prendergast, M. L., Farabee, D. & Cartier, J. (2001). The impact of in-prison therapeutic community programs on prison management. Journal of Offender Rehabilitation, 32 (3), 63-78

Farabee, D., Prendergast, M. L., Cartier, J., Wexler, H., Knight, K. & Anglin, M. D. (1999). Barriers to implementing effective correctional drug treatment programs. The Prison Journal, 79 (2), 150-162

Publications (Manuals)

Prendergast, M. & Cartier, J. (2004, Revised July 2008). Criminal Justice Drug Abuse Treatment Research Studies (CJ-DATS), Transitional Case Management Intervention Manual. National Institute on Drug Abuse. (Not ready for public release)

Prendergast, M. & Cartier J. (2004). Criminal Justice Drug Abuse Treatment Research Studies (CJ-DATS), Transitional Case Management Study – Research Protocol. National Institute on Drug Abuse. (Not ready for public release).

Hall, E. A., Zuniga, R., Cartier, J., Anglin, M. D., Danila, B., Ryan, R. & Mantius, K. (2003). Staying in Touch: A Fieldwork Manual of Tracking Procedures for Locating Substance Abusers in follow-up Studies, 2nd Edition. Los Angeles, CA: UCLA Integrated Substance Abuse Programs.

Last updated - 08/19/2008

Top of Page